glp 1 on medicare Big News for Part D Patients! 🎉 Starting July 1, patients with Medicare Part D may qualify for GLP-1 medications (injection or oral) for as little as $50 per month. GLP-1 CMS Issues Coverage Guidance on

The SURMOUNT-5 trial showed that maximum-dose tirzepatide produces about 47% more weight loss than maximum-dose semaglutide, so they are clearly not equivalent at their respective maximums

At the same time, the glycine group lost 27 percent less lean mass and had better preserved quadriceps muscle mass by 4 percent compared to controls

Understanding when to contact your GP or seek urgent care is essential for patient safety

While qualification is between an individual and their medical providerwhether it be your general practitioner or a telehealth providerdoctors say that people with health concerns related to weight are the best candidates for GLP-1 medications